Koyfin Home > Directory > Health Care > Amgen Inc > Cash and Short-Term Investments

Amgen Inc Cash and Short-Term Investments Chart (AMGN)

Amgen Inc annual/quarterly Cash and Short-Term Investments from 2010 to 2020.
  • Amgen Inc Cash and Short-Term Investments for the quarter ending September 09, 2020 was $12,360m a 27.90% increase of 3,449m year over year
  • Amgen Inc Cash and Short-Term Investments for the last 12 months ending September 09, 2020 was $12,360m a 27.90% increase of 3,449m year over year
  • Amgen Inc Annual Cash and Short-Term Investments for 2019 was $8,911m a -228.85% decrease of -20,393m from 2018
  • Amgen Inc Annual Cash and Short-Term Investments for 2018 was $29,304m a -42.23% decrease of -12,374m from 2017
  • Amgen Inc Annual Cash and Short-Term Investments for 2017 was $41,678m a 8.62% increase of 3,593m from 2016
Other Balance Sheet Metrics:
  • Amgen Inc Total Assets for the quarter ending December 12, 2018 was $66,416m a -7.15% decrease of -4,748m year over year
  • Amgen Inc Other Liabilities for the quarter ending December 12, 2018 was $10,918m a -7.23% decrease of -789m year over year
  • Amgen Inc Total Equity for the quarter ending December 12, 2018 was $12,500m a -24.96% decrease of -3,120m year over year
View Chart On Koyfin

Quarterly AMGN Cash and Short-Term Investments Data

09/2020$12,360m
06/2020$11,421m
03/2020$8,012m
12/2019$8,911m
09/2019$20,853m
06/2019$21,758m
03/2019$26,301m
12/2018$29,304m
09/2018$29,921m
06/2018$29,395m

Annual AMGN Cash and Short-Term Investments Data

2019$8,911m
2018$29,304m
2017$41,678m
2016$38,085m
2015$31,382m
2014$27,026m
2013$19,401m
2012$24,061m
2011$20,641m
2010$17,422m